GH Stock: Price, Earnings History and SEC Filings
Guardant Health, Inc. (GH) last traded at $178.80, down 3.51% on the latest session and up 0.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.89 against an analyst estimate of $-0.74, a miss of 20.3%.
$178.80 -3.51%
1 month+0.25%
52-week high$191.05
52-week low$74.55
Volume1.50M
ExchangeNasdaqGS
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
GH earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Jul 30, 2026 | $-0.89 | $-0.74 | -20.27% |
| Mar 2026 | May 7, 2026 | $-0.85 | $-0.71 | -19.72% |
| Dec 2025 | Feb 19, 2026 | $-1.00 | $-0.81 | -23.46% |
| Sep 2025 | Oct 29, 2025 | $-0.74 | $-0.80 | +7.50% |
GH beat the analyst EPS estimate in 1 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for GH
SEC filing data is not available right now. You can search for GH on SEC EDGAR.
GH news
- Illumina Sinks 13% on Light Q3 Revenue Despite EPS Beat and Raised GuidanceOct 30, 2026 · tikr.com
- Guardant Health (GH) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 ReleaseOct 29, 2026 · finance.yahoo.com
- Guardant Health Applauds New Law Ensuring Access to Colorectal Cancer Screening Innovations with No Cost-Sharing for PennsylvaniansOct 29, 2026 · finance.yahoo.com
- Top Specialty Lab Stocks to Watch This Earnings Season, According to BTIGOct 29, 2026 · finance.yahoo.com
- Can You Still Buy Tempus AI Stock Today?Oct 28, 2026 · trefis.com
- Guardant Health (GH) Stock Looks Undervalued Despite Patent RisksOct 28, 2026 · finance.yahoo.com
- 3 Reasons GH is risky and 1 stock to buy insteadOct 26, 2026 · finance.yahoo.com
- What Happens To Tempus AI Stock If Its Cash Burn Continues?Oct 26, 2026 · trefis.com
About Guardant Health, Inc.
Guardant Health, Inc. (GH) is a US-listed public company on Nasdaq.